ArticleFrontiers in cardiovascular medicine2026
Prognostic value of the triglyceride-glucose Index in elderly patients with acute decompensated heart failure: a one-year mortality analysis.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The triglyceride-glucose (TyG) index, a simple surrogate marker of insulin resistance, has been associated with adverse cardiovascular outcomes. However, data on its prognostic value in elderly patients with acute decompensated heart failure (ADHF) are limited. This study aimed to evaluate the predictive role of the TyG index for one-year all-cause mortality in geriatric ADHF patients. Methods: This retrospective single-center study included 149 patients aged ≥65 years who were hospitalized with ADHF between January 2023 and December 2024. The TyG index was calculated as ln [fasting triglyceride (mg/dL) × fasting glucose (mg/dL)/2]. Patients were stratified into quartiles based on TyG levels, and outcomes were compared across groups. Receiver operating characteristic (ROC) curves, Kaplan-Meier survival analysis, and multivariate Cox regression were applied to evaluate the prognostic performance of the TyG index. Results: Higher TyG quartiles were significantly associated with increased glucose, triglyceride, and inflammatory marker levels ( Conclusion: Elevated TyG levels are associated with increased one-year mortality and reduced survival in elderly ADHF patients. The TyG index provides incremental prognostic value beyond conventional risk factors and in daily clinical practice may serve as a simple, low-cost tool for risk stratification in geriatric heart failure management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.